首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 7-(2-((2-氨基-2-羧基乙基)硫基)乙酰氨基)-7-甲氧基-3-(((1-甲基-1H-四唑-5-基)硫基)甲基)-8-氧代-5-硫代-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸钠

7-(2-((2-氨基-2-羧基乙基)硫基)乙酰氨基)-7-甲氧基-3-(((1-甲基-1H-四唑-5-基)硫基)甲基)-8-氧代-5-硫代-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸钠

sodium 7-(2-((2-amino-2-carboxyethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
100mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

92636-39-0

中文名称

7-(2-((2-氨基-2-羧基乙基)硫基)乙酰氨基)-7-甲氧基-3-(((1-甲基-1H-四唑-5-基)硫基)甲基)-8-氧代-5-硫代-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸钠

英文名称

sodium 7-(2-((2-amino-2-carboxyethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

别名

disodium,7-[[2-(2-amino-2-carboxylatoethyl)sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;(6R,7S)-7-[[[[(2S)-2-Amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt;Cefminox sodium;[6R-(6alpha,7alpha)]-7-[[[(2-Amino-2-carboxyethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt heptahydrate;disodium 7-[[2-[(2-amino-2-carboxylatoethyl)thio]-1-oxoethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;Cefminox Sodium Impurity 24;Alteporina;Tencef

标准英文名

sodium 7-(2-((2-amino-2-carboxyethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

MDL No.

MFCD14636160

分子式

C16H20N7NaO7S3

分子量

541.57

精确分子量

541.05

SMILES

COC1(NC(=O)CSCC(N)C(=O)O)C(=O)N2C(C(=O)[O-])=C(CSC3=NN=NN3C)CSC21.[Na+]

标准SMILES

[Na+].CN1N=NN=C1SCC1CSC2N(C=1C([O-])=O)C(=O)C2(NC(=O)CSCC(N)C(O)=O)OC

用途

Cefminox sodium is indicated for the treatment of infections caused by susceptible bacteria, including: 1. Respiratory tract infections: tonsillitis, peritonsillar abscess, bronchitis, bronchiolitis, bronchiectasis, secondary infections in chronic respiratory diseases, pneumonia, and lung abscess; 2. Urinary tract infections: pyelonephritis and cystitis; 3. Intra-abdominal infections: cholecystitis, cholangitis, and peritonitis; 4. Pelvic infections: pelvic peritonitis, adnexitis, pelvic dead space inflammation, and endometritis; 5. Sepsis.

InChIKey

SBIDXLKJYJVQOE-UHFFFAOYSA-M

安全信息

SureRoute逆合成路线

1.  92636-39-0 逆合成路线 1

—
—
—
—
ACQETW766
92636-39-0
来源: SureRoute

2.  92636-39-0 逆合成路线 2

—
—
ACQETW766
92636-39-0
来源: SureRoute

3.  92636-39-0 逆合成路线 3

—
—
ACQETW766
92636-39-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手